Skip to main content
    C

    Cingulate Inc (CING)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $3.75
    -0.55 (-12.79%)

    Market Cap: $62.53M

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Cingulate Inc (CING) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Cingulate are Cognition Therapeutics (CGTX), Instil Bio (TIL) and NextCure (NXTC). By market cap, Cingulate ranks 7th of the 13 companies on this page; Cellectis SA (CLLS) is the largest at $118.86M.

    Peer Comparison

    CING's revenue growth of 0.0% is in line with the peer median. Like the median peer, it pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Cingulate (CING)$62.53MN/AN/A0.0%N/A0.0%0.00%
    Cognition Therapeutics Inc (CGTX)$64.65MN/AN/A0.0%N/A0.0%0.00%
    Instil Bio Inc. (TIL)$41.23MN/AN/A0.0%-11.9%0.0%0.00%
    NextCure Inc (NXTC)$29.31MN/AN/A0.0%N/A-100.0%0.00%
    Mink Therapeutics Inc (INKT)$47.95MN/A236.3x0.0%N/A0.0%0.00%
    ImageneBio, Inc. (IMA)$43.22MN/A68.5x0.0%N/A0.0%0.00%
    Cardiff Oncology Inc (CRDF)$56.49MN/A115.5x0.0%N/A-14.1%0.00%
    Nkarta Inc (NKTX)$85.23MN/AN/A0.0%N/A0.0%0.00%
    Coherus BioSciences Inc (CHRS)$81.21MN/A1.5x-253.4%-144.8%23.4%0.00%
    Corbus Pharmaceuticals Holding (CRBP)$69.86MN/A13.9x0.0%-106.7%-100.0%0.00%
    iBio, Inc. Common Stock (IBIO)$51.55MN/A735.4x0.0%N/A975.0%0.00%
    Cassava Sciences Inc (SAVA)$114.97MN/AN/A0.0%N/A0.0%0.00%
    Cellectis SA (CLLS)$118.86MN/A1.8x0.0%-74.1%-85.4%0.00%
    Peer median$60.57MN/A68.5x0.0%-90.4%0.0%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Cingulate, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Biotechnology.

    CompanyAboutPeers
    Cognition Therapeutics Inc (CGTX)
    Cognition Therapeutics, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of small molecule therapies targeting...
    CGTX competitors
    Instil Bio Inc. (TIL)
    Instil Bio, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer patients.
    TIL competitors
    NextCure Inc (NXTC)
    NextCure, Inc., a clinical-stage biopharmaceutical company, is dedicated to the discovery and development of novel immunomedicines to treat cancer and other...
    NXTC competitors
    Mink Therapeutics Inc (INKT)
    MiNK Therapeutics, Inc. is a clinical-stage biopharmaceutical company dedicated to the discovery, development, and commercialization of allogeneic...
    INKT competitors
    ImageneBio, Inc. (IMA)
    ImageneBio, Inc., a clinical-stage biotechnology company, develops therapeutics for immunological and inflammatory diseases.
    IMA competitors
    Cardiff Oncology Inc (CRDF)
    Cardiff Oncology, Inc., a clinical-stage biotechnology company, develops drugs for the treatment of cancer.
    CRDF competitors
    Nkarta Inc (NKTX)
    Nkarta, Inc., a clinical-stage biopharmaceutical company, develops and markets cell therapies for the treatment of cancer.
    NKTX competitors
    Coherus BioSciences Inc (CHRS)
    Coherus BioSciences, Inc., a biopharmaceutical company, focuses on the biosimilars and immuno-oncology market primarily in the United States.
    CHRS competitors
    Corbus Pharmaceuticals Holding (CRBP)
    Corbus Pharmaceuticals Holdings, Inc., a clinical-stage pharmaceutical company, focuses on the development and commercialization of novel therapies that target...
    CRBP competitors
    iBio, Inc. Common Stock (IBIO)
    iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States.
    IBIO competitors
    Cassava Sciences Inc (SAVA)
    Cassava Sciences, Inc., a clinical-stage biotechnology company, develops drugs for neurodegenerative diseases. The company is headquartered in Austin, Texas.
    Cellectis SA (CLLS)
    Cellectis SA, a clinical-stage biotechnology company, develops immuno-oncology products based on gene-edited T cells that express chimeric antigen receptors...
    CLLS competitors

    Frequently Asked Questions About CING

    Who are Cingulate's main competitors?

    The companies most similar to Cingulate include Cognition Therapeutics (CGTX), Instil Bio (TIL), NextCure (NXTC), Mink Therapeutics (INKT) and ImageneBio (IMA), listed from the closest match.

    Who is Cingulate's biggest competitor?

    Cellectis SA (CLLS) is the largest of the similar companies at $118.86M; Cognition Therapeutics (CGTX) is the closest match by business profile, size, sector and industry.

    How does CING stock compare with its competitors?

    CING's net margin is 0.0% against a peer median of 0.0%.

    Which of Cingulate's competitors pays a higher dividend?

    Cingulate pays no dividend. None of the similar companies with available yields has a higher forward dividend yield.

    Is Cingulate bigger than its competitors?

    No. Cingulate is 7th by market cap among the 13 companies on this page; the largest is Cellectis SA (CLLS) at $118.86M.